SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

156 patients randomized in multi-center, double-blind, placebo

ATAI

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.